Filing Details
- Accession Number:
- 0001549084-22-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-17 20:22:22
- Reporting Period:
- 2021-06-10
- Accepted Time:
- 2022-06-17 20:22:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1549084 | Ekso Bionics Holdings Inc. | EKSO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1201619 | Steven Sherman | C/O Ekso Bionics Holdings, Inc. 1414 Harbour Way S, Ste. 1201 Richmond CA 94804 | Ceo & Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-10 | 18,265 | $0.00 | 655,673 | No | 4 | A | Direct | |
Common Stock | Disposition | 2022-06-15 | 6,911 | $1.90 | 648,762 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
- This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.
- Represents shares sold by the Reporting Person on June 15, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the Reporting Person's RSUs.
- The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.88 to $1.94, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.